BackTelix Pharmaceuticals Limited Overview

Telix Pharmaceuticals Limited Inventory

Telix Pharmaceuticals Limited's inventory is $39M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$39.01M
↑ 10.16% YoYΔ $3.60M vs prior year quarter

Peer trimmed avg / median

Loading

Telix Pharmaceuticals Limited Inventory History

Loading

Telix Pharmaceuticals Limited vs. peers: Inventory Comparison

Loading

Telix Pharmaceuticals Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Telix Pharmaceuticals Limited (TLX) FAQ

Telix Pharmaceuticals Limited (TLX) currently reports a inventory of $39M as of June 2026. That compares with $35M in the prior-year period — up 10.2% year over year. Use the charts on this page to explore Telix Pharmaceuticals Limited's inventory history and peer comparisons.

Telix Pharmaceuticals Limited's inventory increased from $35M to $39M — a 10.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telix Pharmaceuticals Limited reported $39M in inventory as of June 2026. That compares with $35M in the prior-year period — up 10.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $39M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telix Pharmaceuticals Limited, and consider following TLX for alerts when major investors trade the stock.

Telix Pharmaceuticals Limited is classified in the Healthcare sector. On inventory, it currently shows $39M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLX with unrelated industries.

Questions & Answers